Page 2 of pharmaceutical

Novo Nordisk gearing up for pan-India launch of Wegovy, eyes Rs 8,600 crore in sales.

Novo Nordisk eyes Rs 8,600 crore India sales with weight-loss drug Wegovy

Novo Nordisk is planning a major India launch of its blockbuster weight-loss drug Wegovy, aiming for Rs 8,600 crore in…

Updated: June 24, 2025 19:07 IST

Top Microcap Picks: FIIs Betting Big on Growth & Value. (Image Source: Canva)

2 Fast growing microcaps with high FII attention, on discounts

Foreign institutional investors (FIIs) have been in the news for a good part of the last year for the exodus…

June 21, 2025 05:30 IST

Telma Glenmark, Glenmark Telma 40, Telma AM Glenmark, Telma H Glenmark, Telma 20 Glenmark, Glenmark Telma division products, Telma AM 40 Glenmark, Telma H 40 Glenmark, Telma 80 Glenmark, Glenmark Telma division, Telma 40 Glenmark uses in Hindi, Telma 40 Glenmark price, what is the difference between Telma 40 and Telma AM, is Telma and Telmisartan same, Glenmark Telmisartan, Telma active ingredient, Glenmark Teriflunomide, Teva Glenmark, Telma AMH 40 Glenmark, how does Telma work, what is a Telma, difference between Telma 20 and Telma 40, Telma Beta 50 Glenmark, is Telma H a beta blocker, is Telma 40 a beta blocker, Glenmark para que sirve, Glenmark Pharmaceuticals Brazil, Telma-CT, Glenmark Carvedilol, Glenmark Clotrimazole cream, Telma H 40 uses, Telma H 40 side effects, Telma D, Telma grooming, Glenmark medicine price, Glenmark Pharmaceuticals locations in India, Glenmark ointment list, Telma generic name, Glenmark Estradiol, Glenmark Fingolimod, Glenmark Pharmaceuticals FDA, Glenmark Therapeutics, Glenmark Generics Inc, Glenmark medication, Telma H Glenmark price, Telma Johnson, Telma Garcia, Telma Hyman, Telma H mechanism of action, how does Telma H work, Telma-H, Telma H composition, Telma Madagascar Internet, difference between Telma and Telma AM, Glenmark lawsuit, Glenmark Olmesartan, Telma 40 mg Glenmark, Telma 20 mg Glenmark, Telma H 40 price, Telma Madagascar, Telma medication, Glenmark Telma 80, Glenmark Telma news, Telma Noteboom, Telma North Shore, Telma-NB, Olmesartan Glenmark, Glenmark Ondansetron, Telma parts, Glenmark Pharmaceuticals rating, Glenmark P, Glenmark Topiramate, Glenmark Topiramate reviews, Glenmark recall, Glenmark Pharmaceuticals recall, Glenmark Telma tablet, Tab Telma 40 Glenmark, Glenmark Telma 40 uses, Telma H 40 12.5 side effects, Glenmark Pharmaceuticals US, Glenmark Verapamil, Glenmark IP 40 mg, Glenmark Yaz, Glenmark Zofran, Glenmark Oxcarbazepine, Glenmark Adapalene Gel 0.1, Telma 11, Telma GR, use of Telma 20, Telma 20 ingredients, Telma 20 in US, difference between Telma and Telma CT, difference between Telma and Telma H, Telma 20, Telma trial, Telma 3GO, difference between Telma 40 and Telma H 40, how Telma 40 works, difference between Telma H and Telma 40, Telma 5G, healthcare news, pharma news,

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark said that the FDA has issued a Form 483 upon the conclusion of its inspection at the manufacturing facility.…

June 18, 2025 13:23 IST

Mukul Agarwal's portfolio saw 2 new stock buys, an increased stake in 1 company, 6 reduced holdings, and 6 complete sell-offs. (image Source: Twitter and Shutterstock)

Mukul Agarwal – 2 new buys, 1 added stake, 6 stake cuts, 6 sell offs

Ace investor and one of the Warren Buffetts of India, Mukul Agarwal made substantial changes to his portfolio in the…

June 18, 2025 05:30 IST

Sun Pharma, pharma industry, Dilip Shanghvi, USFDA, manufacturing, compliance issues, US FDA inspection, R&D spend, revenue, specialty revenue

Is the Halol hurdle too high for Sun Pharma? 4 reasons why Nomura sees limited upside potential

Sun Pharma’s Halol issues limit potential; Nomura sees a 17% upside. Stay updated on regulatory developments at Halol facility.

June 17, 2025 12:34 IST

Lupin, pharma sector, pharma, ANDA, drug, US FDA, Chronic Idiopathic Constipation, Prucalopride Tablets

Lupin expands China business: Signs pact with Sino Universal Pharm for lung medicines

While the Sino Universal Pharmaceuticals will get the necessary regulatory approval from the Chinese authorities, Lupin will be responsible for…

June 16, 2025 17:19 IST

Zydus Lifesciences, Pharmaceutical, healthcare, pharma, health

With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business

Zydus Lifesciences plans to acquire US-based Agenus Inc, entering the global biologics CDMO market with two California facilities. The deal…

June 4, 2025 05:09 IST

Madhusudan Kela's Top Picks Plunge 50%: Is it Time to Buy These Discounted Gems? (Image Source: Shutterstock)

Madhusudan Kela’s favourite stocks trading at over 50% discount – Time to buy?

Two of Ace investor and one of India’s Warren Buffett, Madhusudan Kela’s favourite stocks now trade at discounts of over…

May 31, 2025 05:30 IST

Sun Pharma shares fall over 4% today. Here’s what’s behind the drop

Sun Pharmaceuticals share price today, May 23: Sun Pharma shares drop 4.77%, hit by weak earnings; explore future market moves!

May 23, 2025 13:38 IST

pharma sector, Jan Aushadhi, branded pharmaceutical market, volume growth, trade generics, pharmacy chains, acquisitions

Can branded pharma keep pace as Jan Aushadhi scales up? Kotak flags long-term growth risks

India’s branded pharma market is under pressure as Jan Aushadhi and other generic channels gain momentum, impacting volume growth.

Updated: May 22, 2025 10:21 IST

Gland Pharma, fourth quarter, Q4 results, profit, revenue, EBITDA, dividend, investment, US market, collaborations, manufacturing

Gland Pharma Q4 Results: Net profit drops by 3% at Rs 186.54 crore on revenue decline on US market

Gland Pharma posted a 3 per cent decline in consolidated net profit to Rs 186.54 crore in the fourth quarter…

May 20, 2025 18:30 IST

department of pharmaceuticals, DoP, healthcare, pharma, health

Govt invites fresh applications bulk drugs PLI

Govt invites fresh applications under the PLI scheme to boost bulk drug production. Focus on 11 key APIs, KSMs, and…

May 15, 2025 23:50 IST

Indian Pharmaceutical Alliance, addresses the implications of the U.S. Executive Order on drug pricing and its impact on global pharmaceutical innovation and affordability.

Indian generics drug market safe from Trump’s drug price order, says IPA

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to President Trump’s Executive Order…

Updated: May 13, 2025 18:57 IST

CDSCO gives nod to Cipla for distribution and marketing of inhaled insulin in India

Cipla Q4 FY25 results: profit rises 30 percent to Rs 1222 crore

Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the…

May 13, 2025 16:42 IST

Three reasons why markets are falling today: 1000-point cut on Sensex today, Nifty down nearly 1%

Three reasons why markets are falling today: Sensex slides 1,100 points, Nifty down over 1%

The markets are down sharply in early trade after the strong rally on May 12. Here is an analysis of…

Updated: May 13, 2025 13:14 IST

‘Fat shot drug’: Trump’s wild Ozempic story inspires weight loss medication price control plan

Donald Trump appeared to admit being on Ozempic as he laid out his new executive order’s plan to lower prescription…

May 13, 2025 07:28 IST

pharma, market, trump, Sun Pharma, Glenmark, Medicare, Nifty Pharma index

US price cut to seriously dent India’s pharma exports, stocks hit

US President Trump’s move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, especially in…

May 12, 2025 22:18 IST

Nifty rebound, VIX, auto stocks, PSU banks, Maruti, Tata Motors, M&M, Bank Nifty,

These 2 stocks are trading below 10-year PE averages — value picks or value traps?

Maruti and Cipla trade below long-term P/E averages. Both show solid fundamentals, but growth has slowed. Execution on new launches…

May 3, 2025 06:00 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

ICPC 2025: IITs struggle as colleges from Russia, Japan, and China dominate global coding contest

ICPC 2025: IITs struggle as Russia, Japan, and China dominate global coding contest

Laura Loomer said that Americans may no longer have to press a number to listen in English when calling customer care as Trump is mulling blocking outsourcing work to Indian IT companies.

Trump mulling blocking IT outsourcing, says Laura Loomer, pushes to ‘make call centres American again’

Why Markets Aren’t Rising Despite GST Cuts

Market51 min ago

The Indian equity market is facing challenges as the Nifty and Sensex remain stagnant and lag behind other emerging markets. Despite positive factors like GDP growth and GST restructuring, investor sentiment is low due to concerns about slow capex allocation, global trade negotiations, US tariffs, and FII selling. A multi-asset investment approach may be beneficial in this situation.

View all shorts